George, D. J., Heath, E. I., Sartor, A. O., Sonpavde, G., Berry, W. R., Healy, P., … Bruner, D. (2018). Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 36). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.

George, Daniel J., Elisabeth I. Heath, A Oliver Sartor, Guru Sonpavde, William R. Berry, Patrick Healy, Carolyn Winters, et al. “Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 36. AMER SOC CLINICAL ONCOLOGY, 2018.

George DJ, Heath EI, Sartor AO, Sonpavde G, Berry WR, Healy P, et al. Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP). In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2018.

George, Daniel J., et al. “Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).” JOURNAL OF CLINICAL ONCOLOGY, vol. 36, no. 18, AMER SOC CLINICAL ONCOLOGY, 2018.

George DJ, Heath EI, Sartor AO, Sonpavde G, Berry WR, Healy P, Winters C, Riggan C, Anand M, Kephart J, Milowsky MI, Fleming MT, Balaji KC, Zhang T, Bitting RL, Harrison MR, McNamara MA, Freedman JA, Halabi S, Armstrong AJ, Bruner D. Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2018.